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The discussion about health care systems focuses on the dynamics of expenditures and on the 
weak growth of the revenue base. In this discussion it is widely overseen that medical 
expenditures and supply of medical services crucially depend on the compensation of 
physician services. The paper analyses the implementation of an outcome-based payment 
system in the presence of asymmetric information. Two cases are studied in detail: first, the 
common situation of physician’s moral hazard and second, a double moral hazard model. The 
choice of insurance and payment contracts then depends on the characteristics of asymmetric 
information. 
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The political discussion about reforming the health care systems centres on the dynamics of 
expenditures and on missing growth of the revenue base. Especially the structure of financing, 
payment, and regulation in the health care system aggravates the problems in this field of 
economics. But the discussion ignores one characteristic of health care markets, by name the 
unequal distribution of knowledge about health status and treatment options. Asymmetric 
information, i. e. the lack of incentive compatibility, is one of the prevalent topics in the 
health care market. The economic consequences of asymmetric information between two 
contract parties consist in the fact that one party might take advantage of the resulting scope. 
Moreover, in case of diverging individual goals it is possible that individual interests of both 
the physician and the patient are conflicting so that the optimal treatment quality is not always 
in the main interest. 
Although the physician-patient relationship is the key relationship in health care, the starting 
point of health care reforms is the revenue and expenditure situation. Especially in Germany it 
is obvious that health policy changed during the last decade. In the first half of the nineties, 
the discussion was focused on the personal responsibility of the patient. Nowadays, the core 
of the discussion is about the future of financing health care. Thus, personal responsibility of 
the patient and patient orientation has taken a back seat in the debate about the future design 
of the health care system as well as different payment systems for physician services. In 
contrast to the background of this situation, one has to analyse in how far an outcome-based 
payment system can be seen as a step towards efficiency and higher effectiveness in health 
care.
1 The main interest of this paper is to show the consequences of asymmetric information 
for the formulation of insurance and payment contracts when an outcome-based remuneration 
system is implemented. Thereby, in addition to the moral hazard of the physician the patient's 
health related behaviour is also analysed. In this situation of double moral hazard, the insurer 
has to consider the incentives of the contract parameters on medical services and the patient's 
compliance. 
                                                 
1 In other parts of the economy performance-based compensation systems appear on the agenda more often. 
From a theoretical point of view especially the vast literature about principal-agent problems can be seen as a 
starting point for performance- or outcome-based remuneration systems (see e.  g. Holmström (1979) and 
Holmström (1982)). 
 
1The paper is organized as follows. Chapter two discusses basic principles of outcome-based 
compensation and deals with resulting implementation problems. Moreover, a survey about 
the literature concerning theoretical models of physician payment systems in general and 
outcome-based systems in particular is presented. In section three, the basic model is 
developed, followed by the derivation of optimal insurance and remuneration contracts: first, 
in the situation of physician moral hazard, and second if double moral hazard is present. The 
fourth chapter deals with the resulting implications for health policy. The paper ends with a 
conclusion. 
2  Outcome-based payment systems 
2.1  Basic principles 
The behaviour of health care providers and the supply of physician services depend heavily 
on the underlying remuneration system (cf. Advisory Council for the Concerted Action in 
Health Care (2003)). In the case of a fee-for-service remuneration, the physician has an 
incentive to expand the quantity of supplied services. The use of a lump-sum payment instead 
leads to selection effects: flat rate payments encourage the physician to refuse patients with 
difficult diseases and capitation fees have disadvantages if the patient’s treatment is cost-
intensive. In other words, we find a selection with respect to health risks. If the health care 
provider earns a fixed salary it is possible that this has undesired effects concerning his 
productivity. 
The idea behind outcome-based compensation systems is the separation of provision of 
medical services from remuneration. The major targets are a higher effectiveness and an 
efficient health care provision (cf. Advisory Council for the Concerted Action in Health Care 
(1998) and Stade and Stahlecker (2001)). The aim of remunerating the physician according to 
health outcomes is to archive a more appropriate provision of health care services. Therefore, 
the treatment process needs to focus more on the health production process. Therefore, it is 
necessary to verify the medical services supplied. On the one hand, medical procedures have 
to be analysed with respect to their effectiveness and on the other hand, medical facilities 
should be audited regarding their productivity. If someone takes a look at the health care 
system today, a payment system that focuses entirely on health outcomes is not 
  2implemented.
2 One of the main issues for this finding might be that a patient has no ability to 
assess health care quality and professional skills of the physician. By the implementation of 
an outcome-based payment system the patient’s opinion would gain weight in the decision 
process in contrast to a fee-for-service system. 
Generally, what is needed for an outcome-based payment system is a definition of outcomes 
of the health care process. Therefore, three conditions of health outcomes have to be 
considered. One possibility is a full recovery as a starting point for the remuneration of 
physician services. However, situations in which a full recovery is not possible or not 
achievable with maintainable inputs are not covered in this environment. Especially in cases 
of multi-morbidity or chronic diseases, the physician often has to balance between treatment 
success and adverse effects of medical care. Here, an improvement in the health status may be 
an adequate criterion for the remuneration. Moreover, there might be the case in which even 
an improvement is nearly impossible to achieve and stabilising the health status can be 
viewed as a success from a medical perspective. In the end, the implementation of a payment 
system that is only based on the improvement of the health status neglects these medical 
aspects and leads to an unjustified penalization of the provider of medical services. Thus it is 
necessary to find valid indicators to measure the effect of a medical treatment independent of 
the exact definition of health outcome. 
An important factor concerning the implementation of outcome-based payment systems is the 
transparency of the results of the health production process (cf. Advisory Council for the 
Concerted Action in Health Care (1998), p. 65ff.). It is important that the medical providers 
evaluate the medical treatment. In addition to informing the third-party payer it is necessary to 
involve the patient directly in the treatment process. First, the individual comprehension of 
health outcome is necessary to encourage the patient to exhibit the best possible health related 
effort. Second, the patient needs detailed information about the quality of health care. Beyond 
that, implementation of a payment system based on outcomes is only feasible in accordance to 
medical providers and medical associations. They must have a virtual interest for outcome-
based remuneration.
3 Moreover, the position of a gatekeeper for medical services is central 
                                                 
2 For a survey of outcome-based payment systems see Lu and Donaldson (2000). 
3 One advantage of outcome-based payment systems is that medical providers have an interest for training on the 
job in order to improve the service quality. 
 
3for the physician's future position in his relation to patient and insurer.
4 Especially the 
communication between physician and patient is of major importance as well as the mutual 
information transmission is (cf. Schneider (2004)). Here, it is worth mentioning that the 
physician-patient relationship should be settled on a basis of confidence. 
The implementation of such a remuneration system is fairly problematic. One issue is the 
causal connection of outcome and medical services. Generally, a causal interrelationship 
cannot be found because besides medical services numerous other factors like environmental 
conditions, patient's self-healing capabilities and of course the present symptoms influence the 
treatment outcome. Therefore, a deterministic relation between inputs and outputs is 
unascertainable. In practice, we observe several attempts to implement outcome-based or 
performance-oriented remuneration systems of physician services. There exist medical 
guidelines or modular concepts for payment systems. For the first alternative, the physician is 
supposed to treat the patient in accordance with existing guidelines to give him some kind of 
support about decisions concerning therapy and compliance.
5 A modular payment system as a 
second option consists of several components (cf. Advisory Council for the Concerted Action 
in Health Care (1998), p. 69ff.). These are e. g. a flat rate payment for covering the fixed costs 
of treatment, a charge for frequent and standardized services as well as a compensation for 
special services such as home visits or referrals to specialists. Moreover, the provider gets a 
results-orientated bonus in case of a successful treatment which may also be on the basis of a 
‘group result’.
6  
2.2  Theoretical models of outcome-based compensation 
In health economics literature, only few papers explicitly deal with the question of 
compensation in accordance to patient-related health outcomes. The vast majority captures 
only the administrative effects of the implementation of such a payment system (cf. Rochaix 
(1998)). First of all, there is not a clear distinction between outcome-based or performance-
based remuneration. The latter incorporates the idea of guidelines where the input in the 
                                                 
4 This relation between physician, patient and insurer is known as health care triangle (cf. Massialos and Dixon 
(2002), p. 2). 
5 Guidelines are systematically developed, evidence-based statements decided by consensus. They aim at giving 
decision and orientation guide to physicians and patients for medical treatment in the case of certain 
characteristic conditions (cf. Advisory Council for the Concerted Action in Health Care (1998), p. 72). 
6 Even these proposals of outcome-based payment systems face the problems mentioned above. 
  4treatment process is important for its output. In contrast to this, outcome-based payment 
systems focus on the success of the treatment process.  
In the theoretical literature about compensation of ambulatory physician services, most of the 
work concentrates on the contract design for physicians with regard to incentive compatibility 
and efficiency.
7 Performance- or outcome-based payments play only an underpart. Amongst 
these works, Zweifel (1994) was one of the first to develop a model about contracts between 
physician and patient that incorporates elements of outcome and effort. Using a principal-
agent framework with physician's moral hazard, the optimal contract is one that gives the 
physician a share of the treatment outcome in monetary terms. This solution combines 
elements of outcome-based remuneration and effort-related payment systems. As long as a 
higher physician effort leads to a higher probability of a good health outcome, the 
remuneration increases. On the controversy, if the physician only provides a low effort level, 
the probability of a good outcome decreases and therefore, the remuneration decreases too. 
This solution has two main disadvantages. First, the patient’s signing of the contract is subject 
to some kind of urgency if he suffers a severe illness. Second, the patient is not in a position 
to put the physician’s fee into action. It follows that the patient needs help from so called 
complementary agents whose primary tasks are information brokering, negotiation and 
conclusion of contracts (cf. Zweifel, Lehmann and Steinmann (2002)). 
The starting point in the work of Stade and Stahlecker (2001) are the rising health care 
expenditures. They aim at analyzing the influence of different remuneration regimes on 
physician services and therefore on the development of expenditures. Hence, they model the 
relation between a sickness fund and a physician in the context of a principal-agent model 
using a combination of an outcome-based and a service-based remuneration. The physician 
(agent) maximizes his expected profits by treating a patient. The sickness fund acts as a 
principal that maximizes his expected profits with respect to the remuneration parameters. 
The main result is that a combination of outcome- and service-based compensation dominates 
a solely service-based payment system. 
Leonard and Zivin (2003) assume that the outcome of the health production process is 
influenced by both the physician and the patient. This situation is called dual hidden effort. It 
                                                 
7 Examples of research in this field are the models of Ellis and McGuire (1990), Selden (1990), Ma (1994), 
Chalkley and Malcomson (1996), Kwon (1997), Ma and McGuire (1997), Chalkley and Malcomson (1998), De 
Fraja (2000) or Jelovac (2001). 
 
5describes the case where on the one hand the physician is unable to verify the patient's effort 
and on the other hand the patient has no exact knowledge about the medical effort of the 
physician. In this model a fee-for-service compensation is compared to an outcome-based 
remuneration system. The implementation of the negotiated contract lies in the responsibility 
of a third party, namely the employer or regulator. The most remarkable result is that an 
outcome-based payment dominates a fee-for-service payment in the case of a complementary 
relation between physician’s services and patient’s effort. In all other cases a service-based 
remuneration is preferred. 
A model of performance-based payment is presented in Lu, Ma and Yuan (2003). The main 
focus is on the incentives on patient selection and matching if patient heterogeneity and 
asymmetric information are present. Performance-based contracts include a basic 
compensation and an opportunity for additional compensation adapted from measures such as 
quality of care and treatment outcomes. It is assumed that treatment performance depends on 
the severeness of illness and the intensity of treatment. By the use of a performance-based 
compensation system it is possible to reduce the information mismatch between physician and 
patient. Moreover, this form of contracts leads to a better match between illness severity and 
treatment intensity and to more referrals. 
To sum up, in the presented models the analysis concentrates on allocation purposes and 
neglects the interaction between physician and patient. Only in the paper by Leonard and 
Zivin 2003 this subject is discussed. Nevertheless, all of these approaches omit the 
implementation problems associated with performance-based and outcome-based 
remuneration systems. Instead, the paper at hand presents a model of double moral hazard 
between physician and patient concentrating on health policy implications and 
implementation aspects. 
3  Asymmetric information and optimal insurance-provider contracts 
3.1  Structure of the model 
The model describes an agency relationship between physician and patient. In addition, an 
insurance company is incorporated. The model consists of three stages (see figure 1). At the 
first stage, the insurance company decides about the insurance and remuneration contracts. 
Here, the contract parameters are determined. At stage two, nature chooses the patient‘s state 
of health. If he is sick, he will visit the physician and demand medical treatment. In other 
  6cases, the game ends. At stage three, the physician and the patient decide simultaneously 
about the medical services provided and the compliance (health related behaviour). To solve 
this model, we use the method of backward induction, i. e. it is necessary to look at decisions 
about the treatment of physician and patient first and then to incorporate these results in the 
contract stage. 
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For the patient’s utility function U, it is assumed that he owns an initial wealth W and is risk 
avers in disposable income (U is concave). The probability of getting sick p is exogenously 
given, with p∈. This means that the patient has ex ante no influence on his state of health. In 
the case of illness, the patient suffers a health shock in monetary units L. This shock depends 
negatively on the amount of consumed medical services m and on his compliance a, 
respectively. L is a convex function of both variables. This formulation implies diminishing 
marginal benefits of both inputs. 
The patient can purchase insurance for which he has to pay a premium σ. Moreover, in the 
case of treatment, he has to pay a fixed share β of the expenditures for medical treatment 
(coinsurance: 0 <β <1)). These expenditures depend on the two elements of the physician 
remuneration system: First, the outcome of the treatment h and second, a lump sum payment 
Φ. The outcome-indicator h is a random variable that depends on medical services and 
compliance and is restricted to the interval . It is a twice differentiable and increasing function 
of the amount of medical services and compliance h(m, a). Moreover, it is assumed that h is 
concave in m  and  a. If it takes the value 1, the outcome of the medical process can be 
interpreted as a full recovery. In the other extreme case where h=0, medical treatment and 
compliance take no effect on the state of health and so the patient suffers the full loss. Total 
 
7expenditures for medical services, which are equal to the physician’s remuneration are the 
product of outcome and lump sum payment h(m)Φ. 
The patient‘s compliance in the case of illness is associated with disutility D(a) which is a 
convex function of the compliance a so that in this case utility is additive-separable in income 
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If the patient is sick his income-related utility is U1, if he is healthy, he only has to pay the 
insurance premium and his utility is denoted U2, with U1<U2. 
The expected utility of the physician is additive-separable in remuneration and effort. For the 
medication he gets a lump-sum payment Φ that is directly related to health outcome h. In 
detail, this means that if the patient recovers fully (h = 1) the physician will receive the full 
payment Φ. If the health status of the patient remains poor (h = 0) the physician gets no 
payment at all. For any values of h between 0 and 1, he only gets a fraction of Φ. Overall, it is 
assumed that the physician is risk neutral because he is able to spread the income risk over all 
patients. The effort of supplying medical services is C(m) which is a convex function. The 








⎠ EV =p h m ,a Φ - Cm  
(3.2)
 
The insurance company is risk neutral and finances the health care expenditures in the case of 
an illness (p) against a premium σ. The insurance pays for all treatment costs except the co-
payment share β. The insurance supplies this service at actuarial fair premiums on a 








⎠ σ=p 1 -β hm , aΦ   (3.3)
 
  8Considering the information structure, the following two model alternatives are regarded. 
First, in a restricted model it is assumed that the patient reveals no compliance (a = 0). In this 
case, health outcome only depends on the physician’s actions. In the second scenario, 
patient’s compliance influences health outcomes and health shock and the insurer takes 
patient’s compliance into account. 
3.2  Insurance contracts with asymmetric information and no compliance 
To develop some sort of benchmark regime, suppose that the insurance company does not 
account for the patient’s compliance and that the health outcomes as well as the health shock 
depend only on medical services. This corresponds to the situation in which the patient shows 
no health-relevant, treatment-accompanying activities at all. In this case, the patient exhibits 
no compliance and there is no disutility associated with his behaviour. We can then write 




















⎟ ⎠ EU=pU W - σ - β hmΦ - Lm +1 - pUW - σ  
(3.4)
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⎠ σ=p 1 -β hmΦ  
(3.6)
 
The insurer is unable to observe the medical services provided by the physician. The latter 
maximises his expected utility of treatment on stage three (p = 1) by choosing the adequate 
level of medical services.


















                                                 
8 The patient’s decision about his compliance is inapplicable in this situation. 
 
9Here, the marginal medical effort on the right-hand side equals the expected marginal benefits 
on the left. The latter depends on the marginal health outcome and on the lump-sum payment. 
For questions about the contract design it is interesting how an increase in the lump-sum 
payment affects the provision of medical services. Therefore, by applying the implicit-
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It is obvious that a higher payment has a positive effect on the medical services provided by 
the physician. The numerator is positive and equation (3.9) requires that the second order 
derivative of (3.7) in the denominator also is negative. Hence, in a world of asymmetric 
information about the quality of the provided medical services it is important to note how a 
physician reacts if the lump-sum payment changes. The resulting condition is further referred 
to as the incentive compatibility of the physician.  
The implications for the contractual arrangements are analysed at the contract stage. In 
analogy to Stewart (1994) it is assumed that the insurance company maximises patient’s 
expected utility with respect to the coinsurance parameter and the lump-sum payment. The 
insurer considers the following restrictions. First, the physician’s expected utility has to be at 
least as great as his reservation utility V  (participation constraint). Second, the insurance 
premium equals expected expenditures and third, the lump-sum payment has a positive effect 
on medical services (incentive compatibility constraint). The optimisation problem is further 
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To simplify the analysis, the zero profit condition of the insurer as well as the physician’s 
incentive condition are included in the patient‘s expected utility and the physician‘s 
participation constraint. 










It is clear from equation (3.11) that the marginal utility in case of an illness equals marginal 
utility if no treatment is necessary. Because of the concavity of the utility U this is only 
possible if the arguments of the utility function equal each other. For this to be true, two 
conditions must be fulfilled. First, the health shock L has to be absorbed, i.e. m has to be large 
enough so that the patient faces no loss. Second, the patient must not have any out-of-pocket 
expenditure for the medical care. In this case, the coinsurance parameter β is zero and the 
patient is fully insured.
10
The first-order condition with respect to the lump-sum payment Φ after using some algebra is 
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The expected marginal benefits of a higher lump-sum payment on the left-hand side equal the 
expected marginal costs of an increase on the right-hand side.
11 To begin with the benefits on 
the left, they consist of two parts. First, the direct effect of an increase is the expected utility 
gain of the physician because his income is expected to rise. The second effect is indirect and 
results from a better health status of the patient. The higher lump-sum payment raises the 
supply and use of medical services. Furthermore, the monetary health shock decreases. 
Considering the cost of a higher lump-sum payment on the right-hand side one has to 
distinguish between two direct and two indirect effects. The first term denotes the direct 
                                                 
9 A detailed derivation of the results is presented in the appendix. 
10 Note that if the monetary health shock cannot be reduced to zero by the use of medical care the coinsurance 
parameter is negative which means that the patient gets a payment to compensate the loss. This situation is ruled 
out by the assumption that the coinsurance parameter β has to be strictly larger than zero. 
11 The Lagrangian parameter λ can be interpreted as a fixed weight to the physician’s expected utility (cf. Rees 
(1985), p. 21). In this case, a Pareto-optimal situation is regarded under consideration of incentive compatibility 
conditions.  
 
11coinsurance effect. Given a higher lump-sum payment the patient c.  p. has higher out of 
pocket expenditures. The second term is called the direct premium effect. The increase in the 
lump-sum payment c. p. raises medical expenditures. In order that the zero profit condition of 
the insurance company (equation (3.6)) remains valid, the premium has to increase for both 
possible states of health, sick and healthy. The last terms are the indirect coinsurance and 
premium effects. Both appear due to an increase in medical services which results from the 
incentive compatibility condition (3.9). As before, the indirect coinsurance effect is only 
relevant if the patient seeks medical treatment by a physician and the expected rise in the 
insurance premium contemporaneously affects the healthy state of nature. 
Consider that some of the above effects disappear if no coinsurance is incorporated in the 
insurance contract. Together with the result obtained from (3.11) that the coinsurance 
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Here, the direct and indirect coinsurance effects in the case of illness vanish and the new first-
order condition only depends on the marginal utility given a physician visit. The left-hand 
side is unchanged and on the right hand side, only the expected premium effects remain in the 
equation. This means a higher maximum lump-sum payment raises the insurance premium in 
two ways. First, the same health outcome leads c. p. to a higher physician reimbursement. 
Second, the higher lump-sum payment induces a higher level of medical services, which 
enhances the probability of a good health outcome. Moreover, the negative premium effects 
are no more suspended through the coinsurance which means that any rise in expected health 
care expenditures leads to an increase in the insurance premium depending on the probability 
of an illness (p). 
All in all, it is obvious that in a situation with no compliance the patient chooses full 
insurance. The reason is that there is no moral hazard on the patient’s side. In contrast to this, 
the moral hazard of the physician remains a problem. The physician neglects the impact of his 
behaviour on the patient when maximizing his expected utility. For that reason, outcome-
based payments introduced set to balance the sum of expected marginal benefits of the 
physician and the patient and marginal costs of the patient. 
  123.3  Double moral hazard and remuneration contracts 
In contrast to the no-compliance model, we analyse the more general model described in 
chapter 3.1 in the section at hand. Here, the patient’s compliance influences the measure of 
health outcome h positively but at a decreasing rate. Moreover, the monetary health shock L is 
reduced, with La < 0 and Laa > 0. Besides these positive effects compliance is associated with 
disutility which is a convex function. The latter reduces patient’s expected utility in the case 
of a treatment. As before, we analyse different stages of the game. First, both, the physician 
and the patient, maximise their utilities in the case of a medical treatment non-cooperatively 
(stage three). At this point, we face the situation of double moral hazard where neither the 
patient nor the physician can observe or monitor the other one‘s action. In the next stage, 
nature decides about patient’s health status and at the final stage, the insurer sets the insurance 
and payment parameters with respect to the results of the treatment stage. 

































The optimal choice of compliance equals the expected marginal utility and the marginal 
disutility. The marginal benefits are on the left-hand side of equation (3.15). It is clear that the 
loss-reducing effect of a higher compliance (-La) must exceed the negative effect of a higher 
coinsurance (-β haΦ). Applying the implicit-function theorem to equation (3.15) one obtains 
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The denominator of equation (3.16) is the sufficient condition of a utility maximum. Its sign 
depends on the first term in parenthesis. If it is negative then the whole denominator is 
negative, too. The numerator displays the effect of a higher coinsurance on expected marginal 
 
13benefits of compliance. Unfortunately, its sign remains unclear.
12 The first term is positive 
and the second term is negative as long as the term in parenthesis is positive as it is assumed 
for equation (3.15). A higher coinsurance rate leads to an increase in patient’s compliance if, 
in absolute terms, the first term in the nominator is smaller than the second term. In fact, this 
result depends on patient’s influence on the health outcome h and thereby on the physician 
remuneration and on out-of-pocket expenses. 
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Like in equation (3.16) the overall effect of Φ on a is not clear. The denominator corresponds 
to the sufficient condition for a utility maximum and is negative if the first term in parenthesis 
is negative. The numerator shows the effect of a higher lump-sum payment on the marginal 
benefits of compliance. The first term is positive and the second one is negative. As a 
consequence of these results, the effects of coinsurance parameter and lump-sum payment on 
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Simultaneously, the physician maximises his expected utility with respect to the medical 
services at the non-cooperative stage. The maximisation problem and the resulting first order 



















In this non-cooperative environment the physician chooses that level of medical services 
which equals the marginal revenue and the marginal effort of providing health care. The 
                                                 
12 This is in contrast to the effect in Schneider (2004) who analyses a double moral hazard problem with 
conventional insurance and a fee-for-service remuneration system. 
  14former is determined by the higher probability of recovery because of a higher level of 
medical services and the level of the lump-sum payment. Now, one can ask how changes in 
the remuneration system affect the amount of medical services supplied. Here, the lump-sum 
payment Φ influences the choice of medical services because it determines the physician's 
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The numerator is the partial derivation of the outcome indicator with respect to medical 
services and is positive. The denominator is the sufficient condition for a maximum and 
therefore negative. In total, an increase in the outcome-based payment has a positive effect on 
the medical services supplied and is referred to as the physician's incentive constraint. 
The results above ((3.18) and (3.21)) are essential for the derivation of the optimal contract 
parameters in the case of double sided asymmetric information between physician and patient. 
For the contract stage, it is assumed that the insurer cannot observe the individual actions of 
the physician and the patient. Therefore, effort contingent contracts are not possible. Instead, 
the insurance company will maximise the patient‘s expected utility (equation (3.1)) subject to 
the physician‘s participation constraint (equation (3.2)), the zero profit-condition of the 
insurance company (equation (3.3)) and the incentive constraints of the patient and the 
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The maximisation variables are the patient‘s coinsurance parameter and the lump-sum 
payment of the physician. To simplify the analysis the zero profit condition as well as the 
incentive conditions are inserted in the patient‘s expected utility and the physician‘s 
participation constraint. 
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To interpret the condition above it is necessary to take a closer look at the effects of an 
increase in the co-payment parameter. If the compliance increases as a result of a higher β 
(aβ > 0) the left-hand side in equation (3.23) shows the expected marginal utility or revenue 
gains of the patient and the physician. The first term is the marginal rise in physician’s 
income due to a better health outcome. The second term is the direct premium effect of a 
higher coinsurance rate on the patient’s utility, since it is possible for the insurer to lower 
premiums in case of a higher co-payment. In addition, the right-hand side contains the 
marginal utility loss of the patient due to an increase in β. The first two terms on the right are 
the direct and indirect coinsurance effect. Here, for the direct effect, a higher coinsurance rate 
leads to higher out-of pocket expenses and to a loss in utility. Moreover, the higher 
coinsurance rate causes a higher compliance and therefore a better health outcome (indirect 
effect). The third term is the indirect premium effect that leads to an increase in the insurance 
premium because better outcomes increase the expenditures for physician’s services.  
In other cases, if the compliance remains unchanged or if it decreases the indirect effects of a 
change in the coinsurance parameter vanish or change their sign. In detail, the results mainly 
depend on the physician’s remuneration regime and the patient’s influence on the 
remuneration (see equation (3.17)). In case of a fee-for-service remuneration, the patient’s 
compliance has no influence on the physician’s payment because this depends only on the 
medical services supplied, independently of the patient’s actions.
14  
It is clear that the result in (3.23) is different to equation (3.11). In section 3.2, the patient is 
fully insured because the marginal utilities if sick and healthy are equal. Instead, in the double 
                                                 
13 Again, the reader will find a detailed derivation of the results is presented in the appendix. 
14 It is clear that ex ante moral hazard may lead to an increase in medical services to achieve full recovery. In this 
case, the patient’s behaviour influences the remuneration of the physician and the effect of an increase in the co-
payment parameter may be unclear. 
  16moral hazard situation the patient faces a positive coinsurance. The first term on the left is the 
expected marginal income of the physician (indirect effect). The second term shows the 
expected premium reduction for the patient if he is healthy (direct effect). In equilibrium the 
sum of these two effects equals the expected marginal costs of a higher fraction of medical 
expenses the patient has to bear. The first term on the right is the direct expected net premium 
effect if the patient is ill and visits the physician. Here, two partial effects have to be 
distinguished. On the one hand, a higher expenditure share leads to a lower insurance 
premium and on the other hand, it causes a higher out of pocket expense. It is necessary for 
the implementation of a coinsurance that the latter effect dominates the premium effect, i. e. 
that the patient suffers from a financial loss in case of an illness even if he is insured against 
the risk of medical expenditures. This can be described as the incentive effect of a 
coinsurance. The second term on the right-hand side is the expected indirect effect on the 
insurance premium because of a higher coinsurance parameter. If the compliance increases 
through an increase in the coinsurance parameter this leads to a better health outcome h and 
therefore to a higher income of the physician. This again will raise the insurance premium the 
patient has to pay whether he uses medical services or not. An optimal coinsurance has to 
balance these positive effects for both the physician and the patient and the negative effects 
for the patient. 
If one takes a look at the derivation of the maximisation problem with respect to the lump-
sum payment Φ it is evident that the first order condition differs again from the situation in 
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As before, the results depend on the sign of aΦ. If a positive effect of an increasing lump-sum 
payment is assumed (aΦ > 0) then the left-hand side contains the expected marginal benefits 
of the patient and the physician and the right-hand side marks the expected marginal losses in 
patient’s utility. In detail, the first two terms on the left are the direct and the indirect effect of 
a higher lump-sum payment on the physician’s expected income. The direct effect follows 
 
17from the increase in the payment parameter Φ. The indirect effect depends on the influence of 
this parameter on the patient’s compliance and thus on health outcome. The third term is the 
patient’s expected marginal utility of a higher level of medical services due to a higher lump-
sum payment. Because of the higher payment the physician supplies a higher level of medical 
services, which reduces the monetary health shock L. 
The expected marginal losses of the patient can be decomposed as follows. The first term on 
the right is the direct coinsurance effect of a higher lump-sum payment in case of an illness. 
The higher compensation increases out-of-pocket expenditures and reduces the patient’s net 
income. It’s the same case for the second term, the direct premium effect that matters in all 
states of health. The higher reimbursement has to be balanced by increasing the insurance 
premium to guarantee for zero profits. The last two terms are the indirect coinsurance and 
premium effects. Their magnitude depends on the influence of the lump-sum payment on 
medical services and compliance and thus on health outcome h. 
It is obvious that the incorporation of patient's compliance (problem 2) leads to more complex 
first-order conditions. A major difference to problem 1 is the fact that patient’s reactions to 
changes in the insurance and remuneration parameters are uncertain. In the presented model 
we have assumed that patient’s compliance depends positively on a higher coinsurance rate 
and a higher lump-sum payment for the physician. Instead, assuming a negative dependence 
or independency changes the results presented in this section. In case that the coinsurance 
parameter and the lump-sum payment influence patient’s compliance positively, a full 
insurance of the patient is not possible any more. This is due to moral hazard of the patient. 
The difference between equations (3.12) and (3.24), the first-order conditions for the lump-
sum payment, is that in the former case the indirect effects of the lump-sum payment on the 
patient’s choice of actions are neglected. Therefore, given the situation without compliance 
(problem 1) the equilibrium is second best and the situation above that considers the 
compliance (problem 2) can be described as third best. 
4  Implications for health policy 
The key question for future payment systems for physician services is: In which way are we 
able to finance and grant good medicine? Considering the implementation of an outcome-
based compensation for physician services there arise several problems. First, the 
consequences of the insurance and payment parameters β and Φ on patient's compliance are 
  18ambiguous. This is crucial if one takes considers the results presented in section 3.3 because 
interpretation of the first-order conditions depends on the sign of the partial derivatives of a. 
Furthermore, first, it is not only difficult for the insurance company to estimate the effect of 
insurance and payment parameters on patient's compliance and the supply of medical 
services. Second, it is also complex to draw conclusions about the magnitude of these effects. 
As a consequence, the sign of indirect effects in equations (3.23) and (3.24) and therefore the 
interpretation of the first-order conditions are uncertain. 
Second, a related problem is that health outcomes cannot always be identified by the insurer. 
Whether the reported health status is an objective or subjective indicator is not verifiable. In 
fact, one has to ask what the relevant health outcome h for the compensation is. In the 
theoretical model, h serves as an indicator that shows the resulting health status after 
treatment and can be interpreted as the degree of recovery. It does not incorporate that the 
probability of a recovery also depends on the severance of illness, the illness history and other 
more or less random factors. So, medical services and compliance are only two factors 
amongst others that the insurer has to carry in mind when considering outcome-based 
payment systems. For practical issues the indicator h ought to be chosen illness specific. This 
requires much more information about diagnosis, treatment, and patient behaviour which 
raises the costs of implementation. 
At third, the insurer lacks knowledge about the interdependence of medical services and 
compliance in addition to the problem of measuring health outcomes. Two questions are of 
interest: First, how does the choice of medical services influence the patient's compliance (and 
vice versa)? Second, is it possible for the insurer to assign health outcomes to the physician or 
to the patient? The first question is relevant with respect to the implementation of incentives 
for both the physician and the patient by the insurance and payment system in order to obtain 
the optimal treatment quality. If the implementation of a coinsurance results in higher 
compliance but in lower medical services, health outcome might be negatively affected 
independently of the patient’s contact decision. In such a situation, insurance companies or 
governmental regulators face a trade-off: On the one hand, setting the appropriate incentives 
for patients enforces a better compliance and health outcome increases. On the other hand, if 
compliance and medical effort are substitutes, this decreases the probability of a full recovery 
(cf. Schneider (2004)). With respect to the second question, it is clear that the insurer cannot 
draw conclusions about the fraction the patient has contributed to the resulting health status. If 
 
19policy makers do not take this problem into account, it is possible that the physician’s 
compensation depends on a high level on the patient's behaviour. 
Therefore, information about the productivity of medical services and the patient's health-
related behaviour is needed for a successful implementation of an outcome-based 
compensation system. Moreover, the reaction of provider and patient to changes in insurance 
and payment parameters and information about health outcomes are important to archive an 
incentive compatible system. Hence, an improved communication between the actors of the 
health-care triangle (patient, physician and insurer) is one method to incorporate the aims of 
patient and physician. In a system of health care provision and financing, the patient plays a 
central part. On the one hand, he has an interest in a high quality medicine and on the other 
hand, he seeks insurance with an entire financing of treatment costs. This trade-off makes it 
difficult for the insurer to set the appropriate incentives. A system of full insurance supplies 
the patient with incentives to consume medical services at no costs but might not give him 
encouragement to provide the required compliance. A high coinsurance improves his 
compliance in some cases but may lead to a lower demand for medical services. Then, the 
physician has no opportunity to diagnose or treat the patient’s complaints. The crux about the 
patient's compliance is that it is necessary for the success of medical treatment but that setting 
the right incentives seems nearly impossible. Therefore, in addition to medical guidelines, a 
system of guidelines for patients seems necessary to ensure that patient's health related 
behaviour is in accordance to medical treatment. Here, the physician has the position of a 
gatekeeper and is responsible for informing the patient about medical standards and his 
compliance. 
5  Conclusion 
Incentive problems are widespread in health economics. The discussion about the 
remuneration of physician services and its influence on the supply of health care services 
plays an important role in the discussion about the future perspectives of health care systems. 
Outcome-based compensation systems for physician services are one attempt to include the 
quality of health care provision into the remuneration. For ambulatory services, these payment 
systems are barely established yet. Among several reasons especially the problems of 
asymmetric information are an obstacle for the implementation. In detail, these refer to 
problems of mutual asymmetric information in the health care triangle physician-patient-
insurer, the determinants of health outcomes and the incentive effect of insurance and 
  20payment parameters on individual behaviour. Moreover, there is uncertainty about the 
measurement of health outcomes. 
Using a theoretical model of double-sided asymmetric information between physician and 
patient, it is possible to show how the optimal solutions for coinsurance and remuneration 
parameters depend on the asymmetric information. All in all, the problems of asymmetric 
information discussed lead to the conclusion that the patient plays a central part in the health 




The first-order conditions derived in sections 3.2 and 3.3 are simplified conditions resulting 
from the differentiation with respect to the insurance and remuneration parameters in 
conjunction with the first-order conditions of the maximisation problems at stage three. 
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Rearranging leads to equation (3.11). The derivation of the Lagrangian with respect to the 
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Together with the first-order condition of the physician’s maximisation problem (equation 
(3.8)), one can rewrite the condition. This is presented as equation (3.12) in section 3.2. 
  22If patient’s compliance is incorporated into the model the Lagrangian of problem 2 is given 
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Together with equation (3.15), the patient’s condition for a utility maximising compliance, the 
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Using the first-order conditions of the patient’s and physician’s maximization problems 
((3.15) and (3.20) ) condition (A.6) can be written as (3.24). 
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